Alemtuzumab as first-line therapy for B-cell chronic lymphocytic leukemia: long-term follow-up of clinical effects, infectious complications and risk of Richter transformation (Q43946878)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Alemtuzumab as first-line therapy for B-cell chronic lymphocytic leukemia: long-term follow-up of clinical effects, infectious complications and risk of Richter transformation |
scientific article |
Statements
1 reference
Alemtuzumab as first-line therapy for B-cell chronic lymphocytic leukemia: long-term follow-up of clinical effects, infectious complications and risk of Richter transformation (English)
1 reference
C Karlsson
1 reference
S Norin
1 reference
E Kimby
1 reference
B Sander
1 reference
A Porwit Macdonald
1 reference
B Nilsson
1 reference
E Johansson
1 reference
H Mellstedt
1 reference
J Lundin
1 reference
A Osterborg
1 reference
19 October 2006
1 reference
1 reference
20
1 reference
12
1 reference
2204-2207
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference